Palatin Technologies
PTN
#10723
Rank
$13.7 M
Marketcap
$7.70
Share price
-1.41%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -$6.25 Million USD

According to Palatin Technologies's latest financial reports the company's current earnings are $12.88 Million USD. In 2025 the company made an earning of -$9.62 Million USD, an increase over its 2024 earnings that were of -$26.94 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$6.25 Million-35.11%
2025 -$9.62 Million-64.29%
2024 -$26.94 Million-16.9%
2023 -$32.42 Million5.99%
2022 -$30.59 Million-13.7%
2021 -$35.45 Million33.25%
2020 -$26.6 Million-172.11%
2019 $36.88 M2352.33%
2018 $1.5 M-94.13%
2017 $25.62 M-154.92%
2016 -$46.67 Million3.67%
2015 -$45.02 Million878%
2014 -$4.61 Million-72.64%
2013 -$16.83 Million-33.11%
2012 -$25.15 Million77.71%
2011 -$14.16 Million
2003 -$23.97 Million29.93%
2002 -$18.45 Million36.18%
2001 -$13.55 Million
1999 -$11.24 Million6.04%
1998 -$10.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$25.97 B-416,306.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$14.66 B-235,029.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$0.79 B-12,897.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-$11.72 Million 87.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.19 B-3,151.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-$0.12 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
$0.11 B-1,958.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-$29.49 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-$57.95 Million 828.28%๐Ÿ‡บ๐Ÿ‡ธ USA